{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:32:50Z","timestamp":1793406770911,"version":"4.5.0"},"reference-count":80,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FIS PI14\/00029"],"award-info":[{"award-number":["FIS PI14\/00029"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["Explora BIO2014-61377"],"award-info":[{"award-number":["Explora BIO2014-61377"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2017.00007","type":"journal-article","created":{"date-parts":[[2017,2,9]],"date-time":"2017-02-09T22:31:04Z","timestamp":1486679464000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["How to Face Chronic Liver Disease: The Sinusoidal Perspective"],"prefix":"10.3389","volume":"4","author":[{"given":"Anabel","family":"Fern\u00e1ndez-Iglesias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Gracia-Sancho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,2,10]]},"reference":[{"issue":"9859","key":"B1","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"issue":"9615","key":"B2","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/S0140-6736(08)60383-9","article-title":"Liver cirrhosis","volume":"371","author":"Schuppan","year":"2008","journal-title":"Lancet"},{"issue":"9930","key":"B3","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/S0140-6736(14)60121-5","article-title":"Liver cirrhosis","volume":"383","author":"Tsochatzis","year":"2014","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension","volume":"63","author":"de Franchis","year":"2015","journal-title":"J Hepatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"S121","DOI":"10.1016\/j.jhep.2015.01.003","article-title":"Evolution in the understanding of the pathophysiological basis of portal hypertension: how changes in paradigm are leading to successful new treatments","volume":"62","author":"Bosch","year":"2015","journal-title":"J Hepatol"},{"issue":"2","key":"B6","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s12072-015-9613-5","article-title":"New cellular and molecular targets for the treatment of portal hypertension","volume":"9","author":"Gracia-Sancho","year":"2015","journal-title":"Hepatol Int"},{"issue":"6","key":"B7","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/cld.604","article-title":"Mechanisms of portal hypertension: bench to bedside","volume":"8","author":"Gracia-Sancho","year":"2016","journal-title":"Clin Liver Dis"},{"issue":"3","key":"B8","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.jhep.2016.04.018","article-title":"Sinusoidal communication in liver fibrosis and regeneration","volume":"65","author":"Marrone","year":"2016","journal-title":"J Hepatol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.jhep.2010.07.004","article-title":"Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: new targets for the treatment of portal hypertension?","volume":"53","author":"Thabut","year":"2010","journal-title":"J Hepatol"},{"issue":"1","key":"B10","doi-asserted-by":"publisher","first-page":"G197","DOI":"10.1152\/ajpgi.00190.2007","article-title":"The role of hepatic arterial flow on portal venous and hepatic venous wedged pressure in the isolated perfused CCl4-cirrhotic liver","volume":"295","author":"Zipprich","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"6","key":"B11","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/ar.20669","article-title":"Regulation of sinusoidal perfusion in portal hypertension","volume":"291","author":"Reynaert","year":"2008","journal-title":"Anat Rec (Hoboken)"},{"issue":"1\u20132","key":"B12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cca.2005.06.014","article-title":"Mechanisms of liver fibrosis","volume":"364","author":"Tsukada","year":"2006","journal-title":"Clin Chim Acta"},{"issue":"9","key":"B13","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1136\/gut.2007.144584","article-title":"Mechanisms of extrahepatic vasodilation in portal hypertension","volume":"57","author":"Hennenberg","year":"2008","journal-title":"Gut"},{"issue":"22","key":"B14","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1038\/sj.onc.1209083","article-title":"A crucial function of PDGF in TGF-beta-mediated cancer progression of hepatocytes","volume":"25","author":"Gotzmann","year":"2006","journal-title":"Oncogene"},{"issue":"7","key":"B15","doi-asserted-by":"publisher","first-page":"G749","DOI":"10.1152\/ajpgi.00138.2014","article-title":"PDGF receptor-\u03b1 promotes TGF-\u03b2 signaling in hepatic stellate cells via transcriptional and posttranscriptional regulation of TGF-\u03b2 receptors","volume":"307","author":"Liu","year":"2014","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1582-4934.2006.tb00292.x","article-title":"Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-\u03b2 as major players and therapeutic targets","volume":"10","author":"Gressner","year":"2006","journal-title":"J Cell Mol Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/hep.20798","article-title":"Early response of alpha2(I) collagen to acetaldehyde in human hepatic stellate cells is TGF-beta independent","volume":"42","author":"Svegliati-Baroni","year":"2005","journal-title":"Hepatology"},{"issue":"6","key":"B19","doi-asserted-by":"publisher","first-page":"G1093","DOI":"10.1152\/ajpgi.00292.2009","article-title":"Hedgehog pathway activation and epithelial-to-mesenchymal transitions during myofibroblastic transformation of rat hepatic cells in culture and cirrhosis","volume":"297","author":"Choi","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"9","key":"B20","doi-asserted-by":"publisher","first-page":"e23943","DOI":"10.1371\/journal.pone.0023943","article-title":"Hedgehog signaling antagonist promotes regression of both liver fibrosis and hepatocellular carcinoma in a murine model of primary liver cancer","volume":"6","author":"Philips","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"B21","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jhep.2007.07.032","article-title":"Sonic hedgehog is an autocrine viability factor for myofibroblastic hepatic stellate cells","volume":"48","author":"Yang","year":"2008","journal-title":"J Hepatol"},{"issue":"7","key":"B22","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1007\/s00018-015-2127-4","article-title":"Hedgehog signaling pathway: a novel model and molecular mechanisms of signal transduction","volume":"73","author":"Gorojankina","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"B23","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.jhep.2010.10.003","article-title":"Hedgehog signaling in the liver","volume":"54","author":"Omenetti","year":"2011","journal-title":"J Hepatol"},{"issue":"29","key":"B24","doi-asserted-by":"publisher","first-page":"6652","DOI":"10.3748\/wjg.v22.i29.6652","article-title":"MicroRNAs in liver fibrosis: focusing on the interaction with hedgehog signaling","volume":"22","author":"Hyun","year":"2016","journal-title":"World J Gastroenterol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.biocel.2010.10.015","article-title":"The role of Hedgehog signaling in fibrogenic liver repair","volume":"43","author":"Choi","year":"2011","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"B26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ctrv.2013.08.003","article-title":"Inhibition of Hedgehog signaling in the gastrointestinal tract: targeting the cancer microenvironment","volume":"40","author":"Merchant","year":"2014","journal-title":"Cancer Treat Rev"},{"issue":"5","key":"B27","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1053\/j.gastro.2008.07.065","article-title":"Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis","volume":"135","author":"Taura","year":"2008","journal-title":"Gastroenterology"},{"issue":"2","key":"B28","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.cell.2012.05.041","article-title":"Noncanonical Wnt signaling maintains hematopoietic stem cells in the niche","volume":"150","author":"Sugimura","year":"2012","journal-title":"Cell"},{"issue":"1","key":"B29","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.bbrc.2007.12.085","article-title":"Canonical Wnt signaling maintains the quiescent stage of hepatic stellate cells","volume":"367","author":"Kordes","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"B30","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1053\/j.gastro.2015.02.056","article-title":"\u03b2-catenin signaling and roles in liver homeostasis, injury, and tumorigenesis","volume":"148","author":"Monga","year":"2015","journal-title":"Gastroenterology"},{"issue":"2","key":"B31","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1053\/jhep.2002.31432","article-title":"The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough","volume":"35","author":"Wiest","year":"2002","journal-title":"Hepatology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1136\/gut.2010.220913","article-title":"Endothelial expression of transcription factor Kruppel-like factor 2 and its vasoprotective target genes in the normal and cirrhotic rat liver","volume":"60","author":"Gracia-Sancho","year":"2011","journal-title":"Gut"},{"issue":"8","key":"B33","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1078\/0171-9335-00182","article-title":"The bcl, NFkappaB and p53\/p21WAF1 systems are involved in spontaneous apoptosis and in the anti-apoptotic effect of TGF-beta or TNF-alpha on activated hepatic stellate cells","volume":"80","author":"Saile","year":"2001","journal-title":"Eur J Cell Biol"},{"issue":"4","key":"B34","doi-asserted-by":"publisher","first-page":"G763","DOI":"10.1152\/ajpgi.00300.2004","article-title":"Sinusoidal endothelial COX-1-derived prostanoids modulate the hepatic vascular tone of cirrhotic rat livers","volume":"288","author":"Graupera","year":"2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"4","key":"B35","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1002\/hep.22166","article-title":"Increased oxidative stress in cirrhotic rat livers: a potential mechanism contributing to reduced nitric oxide bioavailability","volume":"47","author":"Gracia-Sancho","year":"2008","journal-title":"Hepatology"},{"issue":"2","key":"B36","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1136\/gutjnl-2011-301494","article-title":"Hedgehog signalling regulates liver sinusoidal endothelial cell capillarisation","volume":"62","author":"Xie","year":"2012","journal-title":"Gut"},{"issue":"1","key":"B37","doi-asserted-by":"publisher","first-page":"320.e","DOI":"10.1053\/j.gastro.2008.09.066","article-title":"Liver cell-derived microparticles activate Hedgehog signaling and alter gene expression in hepatic endothelial cells","volume":"136","author":"Witek","year":"2009","journal-title":"Gastroenterology"},{"issue":"4","key":"B38","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1182\/blood-2009-12-256644","article-title":"Hedgehog regulates distinct vascular patterning events through VEGF-dependent and -independent mechanisms","volume":"116","author":"Coultas","year":"2010","journal-title":"Blood"},{"issue":"4","key":"B39","doi-asserted-by":"publisher","first-page":"G757","DOI":"10.1152\/ajpgi.00017.2004","article-title":"Rat liver sinusoidal endothelial cell phenotype is maintained by paracrine and autocrine regulation","volume":"287","author":"DeLeve","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"3","key":"B40","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/cmi.2015.104","article-title":"Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies","volume":"13","author":"Ju","year":"2016","journal-title":"Cell Mol Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jhep.2014.03.014","article-title":"Inflammation and portal hypertension \u2013 the undiscovered country","volume":"61","author":"Mehta","year":"2014","journal-title":"J Hepatol"},{"issue":"2","key":"B42","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jhep.2009.10.030","article-title":"NF-kB signalling: embracing complexity to achieve translation","volume":"52","author":"Chakraborty","year":"2010","journal-title":"J Hepatol"},{"issue":"2","key":"B43","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nrgastro.2010.213","article-title":"NF-\u03baB in the liver \u2013 linking injury, fibrosis and hepatocellular carcinoma","volume":"8","author":"Luedde","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"B44","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1136\/gutjnl-2011-300304","article-title":"Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury","volume":"61","author":"Baeck","year":"2012","journal-title":"Gut"},{"key":"B45","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3389\/fphys.2012.00056","article-title":"Functional role of monocytes and macrophages for the inflammatory response in acute liver injury","volume":"3","author":"Zimmermann","year":"2012","journal-title":"Front Physiol"},{"issue":"11","key":"B46","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.1172\/JCI41732","article-title":"Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice","volume":"120","author":"Berres","year":"2010","journal-title":"J Clin Invest"},{"issue":"5","key":"B47","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1002\/hep.23894","article-title":"The fractalkine receptor CX3CR1 protects against liver fibrosis by controlling differentiation and survival of infiltrating hepatic monocytes","volume":"52","author":"Karlmark","year":"2010","journal-title":"Hepatology"},{"issue":"2","key":"B48","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jhep.2007.03.019","article-title":"Kupffer cell activation in normal and fibrotic livers increases portal pressure via thromboxane A(2)","volume":"47","author":"Steib","year":"2007","journal-title":"J Hepatol"},{"issue":"4","key":"B49","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1189\/jlb.1204747","article-title":"Inhibition of 5-lipoxygenase-activating protein abrogates experimental liver injury: role of Kupffer cells 17","volume":"78","author":"Titos","year":"2005","journal-title":"J Leukoc Biol"},{"issue":"4","key":"B50","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S1665-2681(19)30840-3","article-title":"Long term changes in liver histology following treatment of chronic hepatitis C virus","volume":"13","author":"Shiffman","year":"2014","journal-title":"Ann Hepatol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13256","article-title":"Direct antiviral agent treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers fibrosis-4 score and aspartate aminotransferase-platelet ratio index","author":"Bachofner","year":"2016","journal-title":"Liver Int"},{"issue":"7","key":"B52","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1053\/j.gastro.2004.03.009","article-title":"Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking","volume":"126","author":"Issa","year":"2004","journal-title":"Gastroenterology"},{"issue":"2","key":"B53","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/14728214.2016.1184647","article-title":"Emerging therapies for portal hypertension in cirrhosis","volume":"21","author":"Nair","year":"2016","journal-title":"Expert Opin Emerg Drugs"},{"issue":"1","key":"B54","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/hep.21673","article-title":"Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA\/Rho-kinase and activation of endothelial nitric oxide synthase","volume":"46","author":"Trebicka","year":"2007","journal-title":"Hepatology"},{"issue":"4","key":"B55","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.jhep.2010.04.025","article-title":"Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells","volume":"53","author":"Trebicka","year":"2010","journal-title":"J Hepatol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1136\/gutjnl-2014-308800","article-title":"Statins, Rho GTPases and KLF2: new mechanistic insight into liver fibrosis and portal hypertension","volume":"64","author":"Trebicka","year":"2015","journal-title":"Gut"},{"issue":"1","key":"B57","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jhep.2012.08.026","article-title":"The transcription factor KLF2 mediates hepatic endothelial protection and paracrine endothelial-stellate cell deactivation induced by statins","volume":"58","author":"Marrone","year":"2013","journal-title":"J Hepatol"},{"issue":"9","key":"B58","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1136\/gutjnl-2014-308338","article-title":"KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statins","volume":"64","author":"Marrone","year":"2014","journal-title":"Gut"},{"issue":"S1","key":"B59","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/hep.28800","article-title":"Hepatic microcirculatory phenotype in aging: mildly dysfunctional in health but markedly deteriorated in chronic liver injury","volume":"64","author":"Maeso-Diaz","year":"2016","journal-title":"Hepatology"},{"issue":"5","key":"B60","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1053\/j.gastro.2009.01.043","article-title":"Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial","volume":"136","author":"Abraldes","year":"2009","journal-title":"Gastroenterology"},{"issue":"5","key":"B61","doi-asserted-by":"publisher","first-page":"1160.e","DOI":"10.1053\/j.gastro.2016.01.004","article-title":"Addition of simvastatin to standard therapy for the prevention of variceal rebleeding does not reduce rebleeding but increases survival in patients with cirrhosis","volume":"150","author":"Abraldes","year":"2016","journal-title":"Gastroenterology"},{"issue":"2","key":"B62","doi-asserted-by":"publisher","first-page":"430.e","DOI":"10.1053\/j.gastro.2015.10.007","article-title":"Statins are associated with a decreased risk of decompensation and death in veterans with hepatitis C-related compensated cirrhosis","volume":"150","author":"Mohanty","year":"2016","journal-title":"Gastroenterology"},{"issue":"4","key":"B63","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1159\/000374099","article-title":"Pathophysiology and a rational basis of therapy","volume":"33","author":"Gracia-Sancho","year":"2015","journal-title":"Dig Dis"},{"issue":"10","key":"B64","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.freeradbiomed.2005.06.014","article-title":"Oxidative stress disrupts nitric oxide synthase activation in liver endothelial cells","volume":"39","author":"Karaa","year":"2005","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"B65","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/hep.21080","article-title":"Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension","volume":"43","author":"Hernandez-Guerra","year":"2006","journal-title":"Hepatology"},{"issue":"3","key":"B66","doi-asserted-by":"publisher","first-page":"584","DOI":"10.3945\/ajcn.112.040469","article-title":"Postprandial effects of dark chocolate on portal hypertension in patients with cirrhosis: results of a phase 2, double-blind, randomized controlled trial","volume":"96","author":"De Gottardi","year":"2012","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"B67","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.jhep.2012.12.012","article-title":"Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats","volume":"58","author":"Di Pascoli","year":"2013","journal-title":"J Hepatol"},{"issue":"11","key":"B68","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1111\/jphp.12283","article-title":"Curcumin affects \u03b2-catenin pathway in hepatic stellate cell in vitro and in vivo","volume":"66","author":"Cui","year":"2014","journal-title":"J Pharm Pharmacol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jnutbio.2015.08.016","article-title":"Tea polyphenols epigallocatechin gallete and theaflavin restrict mouse liver carcinogenesis through modulation of self-renewal Wnt and hedgehog pathways","volume":"27","author":"Sur","year":"2016","journal-title":"J Nutr Biochem"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.jhep.2013.07.001","article-title":"Wnt signaling and hepatocarcinogenesis: molecular targets for the development of innovative anticancer drugs","volume":"59","author":"Pez","year":"2013","journal-title":"J Hepatol"},{"issue":"4","key":"B71","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1002\/hep.28763","article-title":"Upstream regulators of hepatic Wnt\/\u03b2-catenin activity control liver metabolic zonation, development, and regeneration","volume":"64","author":"Clerbaux","year":"2016","journal-title":"Hepatology"},{"issue":"5","key":"B72","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1002\/hep.21651","article-title":"WNT\/\u03b2-catenin signaling in liver health and disease","volume":"45","author":"Thompson","year":"2007","journal-title":"Hepatology"},{"issue":"6","key":"B73","doi-asserted-by":"publisher","first-page":"e0158156","DOI":"10.1371\/journal.pone.0158156","article-title":"Antifibrotic effects of the dual CCR2\/CCR5 antagonist cenicriviroc in animal models of liver and kidney fibrosis","volume":"11","author":"Lefebvre","year":"2016","journal-title":"PLoS One"},{"issue":"48","key":"B74","doi-asserted-by":"publisher","first-page":"6228","DOI":"10.1038\/onc.2008.300","article-title":"NF-\u03baB signaling, liver disease and hepatoprotective agents","volume":"27","author":"Sun","year":"2008","journal-title":"Oncogene"},{"issue":"S1","key":"B75","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/hep.28800","article-title":"The pan caspase inhibitor Emricasan improves the hepatic microcirculatory dysfunction of CCl4-cirrhotic rats leading to portal hypertension amelioration and cirrhosis regression","volume":"64","author":"Gracia-Sancho","year":"2016","journal-title":"Hepatology"},{"issue":"S1","key":"B76","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/hep.28800","article-title":"Emricasan (IDN-6556) orally for 6 months in patients with non-alcoholic steatohepatitis (NASH) cirrhosis decreases the progression of MELD score and improves liver function","volume":"64","author":"Frenette","year":"2016","journal-title":"Hepatology"},{"issue":"S1","key":"B77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/hep.28796","article-title":"Liraglutide de-activates hepatic stellate cells improving liver microvascular dysfunction and fibrosis in rats with chronic liver disease","volume":"64","author":"Mesquita","year":"2016","journal-title":"Hepatology"},{"key":"B78","doi-asserted-by":"publisher","first-page":"33453","DOI":"10.1038\/srep33453","article-title":"FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis","volume":"6","author":"Verbeke","year":"2016","journal-title":"Sci Rep"},{"issue":"9972","key":"B79","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","article-title":"Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial","volume":"385","author":"Neuschwander-Tetri","year":"2015","journal-title":"Lancet"},{"issue":"4","key":"B80","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1096\/fj.14-268425","article-title":"Lysyl oxidase activity contributes to collagen stabilization during liver fibrosis progression and limits spontaneous fibrosis reversal in mice","volume":"30","author":"Liu","year":"2016","journal-title":"FASEB J"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmed.2017.00007\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T10:00:44Z","timestamp":1568800844000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmed.2017.00007\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,10]]},"references-count":80,"URL":"https:\/\/doi.org\/10.3389\/fmed.2017.00007","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,10]]}}}